# US 2017/0281758 A1 · Calicheamicin antibody drug conjugates linking an amidoacetyl group to a sugar moiety on calicheamicin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281758 A1
- Document ID: US20170281758A1
- Status: Published application
- Kind: A1
- Application number: 15/472,965
- Filed: 2017-03-29
- Published: 2017-10-05
- Earliest claimed: 2016-03-29
- Assignees: Sorrento Therapeutics, Inc.
- Applicants: Sorrento Therapeutics, Inc.
- Inventors: Gang Chen; Alisher B. Khasanov; Hong Zhang; Tong Zhu; Zhenwei Miao
- Web page: https://patentgrep.com/patent/US20170281758A1

## CPC

- A61K 39/395: Antibodies (agglutinins A61K38/36 {; as drug carriers A61K47/50}); Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K 47/6809: {Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin}
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- C07K 16/2863: {against receptors for growth factors, growth regulators}
- C07K 16/32: against translation products of oncogenes
- A61K 2039/505: {comprising antibodies}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

There is disclosed a calicheamicin antibody drug conjugate comprising a linking amidoacetyl group covalently bound to a sugar moiety on calicheamicin or linking to sulfur atom on calicheamicin through disulfide bond.

## Claims

### Claim 1

An ADC comprising a structure of Formula II
AbL1-L2-D)n (II)
or a pharmaceutically acceptable salt thereof, wherein:
Ab is a monoclonal antibody;
L1-L2together are a linker selected from the group consisting of:
wherein the wavy line indicates a point of attachment to an Ab;
L2 is a linker; wherein L2 is selected from the group consisting of an amino acid, a peptide, —(CH2)m—, —(CH2CH2O)m—, PAB, Val-Cit-PAB, Val-Ala-PAB, Ala-Ala-Asn-PAB, and combinations thereof, wherein m is an integer from 0 to 10;
D is calicheamicin; and
n is 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10.

### Claim 2 (depends on 1)

The ADC of claim 1, wherein D has the structure of Formula III
or a pharmaceutically acceptable salt thereof;
wherein the wavy line indicates the point of attachment to L2; and
wherein R1 is selected from the group consisting of C1-C8 alkyl, —(CH2CH2O)n—, isopropyl, glucose, galactose, mannose, glucosamine, C1-C8 alkyl-OH, and combinations thereof, and
where n=1-30

### Claim 3 (depends on 1)

The ADC of claim 1, or a pharmaceutically acceptable salt thereof, wherein R1 is selected from the group consisting of: isopropyl,
wherein the wavy line indicates a point of attachment to the sulfur on calicheamicin.

### Claim 4 (depends on 1)

The ADC of claim 1, wherein the structure of Formula II has a structure selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.

### Claim 5 (depends on 1)

The ADC of claim 1, wherein the structure of Formula II has a structure selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.

### Claim 6

A compound having the structure:
or a pharmaceutically acceptable salt thereof.

### Claim 7 (depends on 6)

The compound of claim 6, wherein Ab is antibody of an IgG class that binds to a c-Met epitope with a binding affinity of at least 10−6M.
